Lack of new sales update, tell me, just what does the sales staff do with their day?
I ignore the noise, however the apparent lack of deals/adoption surely doesn't entice funds to truly accumulate
I await the response of inst holding #'s that defy direction of pps
All those new bodies need to pay their keep
As per usual script, unable to hold a gain, Murphy is long past due with sales update, silence is clearly not golden
No sales to report?
Just what is going on to produce revs?
No other pharmas buying liver?
Murphy needs to provide update of some sort
No news isn't good news
Last December if i remember correctly volume was in 300-400k
I'd like an update as to what sales staff has been up to....if they're getting paid commission, they need a kick in the pants
Been far too long since pr about a contract
I have been in this since the pennies, selling half at 11 and watching it get pummeled since.
I did add 5k shares at 2.03, as I believe this will bear fruit.
It'd probably be best I didn't visit ONVO as I'd give Murphy both barrels for the lack of specifics as to what is in the deals done thus far.
This isn't academia.
If one applied "publish or perish" Murphy wouldn't advance from Asst to Assoc Professor, to move closer to gaining tenure.
A greater sense of urgency, IMO, is paramount.
There is always someone out there looking to build a better mousetrap
Moo, CC's like they had certainly aren't helpful, in addition to the secondary under the auspices of getting more inst $ and expansion...
I don't know what they're paying sales staff, but they need a real kick in the rear, or a change in compensation to a full commission basis so deals get closed.
Murphy has created this vacuum, and despite the rash of hirings...IR, General Mgr, lab managers, et al....
There has to be change in transparency about details of deals, and the rate of closed deals, because they've increased their cash burn rate substantially.
Way past time for some news of a substantial deal with some real dollars of revenue up front.
Expect this will go sub 2 in the coming weeks or sooner.
Time Murphy made good on that 80% closure rate and shareholders got info that they frankly deserve.
Murphy is exhibiting all the signs of a megalomaniac
He lacks the requisite skills needed by a CEO
Maybe he's good in the lab, but the corner office is not jus forte
Many good ideas died
Mismanagement, ineptness has crippled this company
Market is far more efficient than the speed with which these clowns can print tissue
Absent major inst support, strong odds this dies on the vine
Best hope may be someone buying out company at fire sale price
Murphy, by his own admission, has no leverage